🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Stereotaxis, Inc.

STXS Healthcare
$1.85 +$0.03 (1.65%)
Market Cap: $180.33 M
Gurus Holding
2
Popularity Rank
#3765
% of Shares Held
0.50%
Net Activity (Q4 2025)
+$151,864.34

Guru Ownership Trend

Guru Analysis for Stereotaxis, Inc. (STXS)

Stereotaxis, Inc. (STXS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $893,346.5.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $151,864.34 net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 17.9%. Conversely, Cliff Asness reduced exposure by 5.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$156,400
Total Buy Value
New Buys 0
Additions 1
-$4,535.66
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
1

FAQs for Stereotaxis, Inc. (STXS)

Major holders include Renaissance Technologies (RenTech) ($1.03 M), Cliff Asness ($79,328). According to the latest reported data, 2 tracked investment managers collectively hold approximately 482,890 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $151,864.34, with 1 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited STXS. The total reported sell value was $4,535.66.

Yes, 0 managers opened new positions in STXS, and 1 increased their existing holdings. The total reported buy value was $156,400.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 17.9% 448,400 $1.03 M Q4 2025
0.00% Reduce -5.4% 34,490 $79,328 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form